Navigation Links
HBO, UCSD Shiley-Marcos Alzheimer's Disease Research Center, The Alzheimer's Association San Diego/Imperial Chapter and The Neurosciences Institute Present an Advance Screening of THE ALZHEIMER'S PROJECT: 'MOMENTUM IN SCIENCE'
Date:4/9/2009

FREE TO THE PUBLIC

Panel Discussion To Follow With Local Leading Alzheimer's Experts Featured In Film

SAN FRANCISCO, April 9 /PRNewswire/ -- A free screening of HBO Documentary Films' THE ALZHEIMER'S PROJECT: MOMENTUM IN SCIENCE will be held at The Neurosciences Institute (10640 John Jay Hopkins Dr.) in San Diego on Tuesday, May 5, 2009 at 6:00pm. Following the film, Hal Clement, anchor-reporter with 10News in San Diego will moderate a discussion with a distinguished panel of local, leading Alzheimer's researchers, including experts who appear in the films.

Panelists are Paul Aisen, MD, Director, Alzheimer's Disease Cooperative Study, and Professor of Neurosciences at UC San Diego School of Medicine; Carl Cotman, PhD, Professor of Neurobiology and Behavior, UC Irvine; James Brewer, MD, PhD, Assistant Professor of Neurosciences and Radiology, UC San Diego and David P. Salmon, PhD, Professor of Neurosciences, UC San Diego.

The event is free, but seating is limited. The public is asked to rsvp at https://homeboxoffice.com/rsvp/alzheimersSD or by calling 1.888.560.5856.

THE ALZHEIMER'S PROJECT features a four-part documentary series, 15 short supplemental films, a robust website, a nationwide community-based information and outreach campaign and a book published by Public Affairs Books. The MOMENTUM IN SCIENCE film is a two-part, state-of-the-science odyssey that takes viewers inside the laboratories and clinics of 25 leading scientists and physicians, revealing some of the most cutting-edge research advances. Part 1 debuts on HBO MONDAY, MAY 11 (8:00pm), followed by Part 2 on TUESDAY, MAY 12 (8:00pm).

Two years in the making, MOMENTUM IN SCIENCE details the current explosion of knowledge within the scientific and medical communities, from imaging the earliest signs of Alzheimer's, to understanding the roles that genetics and lifestyle might play, to the tremendous progress being made in the effort to develop drugs to treat or even prevent the disease.

The University of California, San Diego Shiley-Marcos Alzheimer's Disease Research Center was established in 1984 to translate research advances in Alzheimer's disease into improved diagnosis and care for patients, while focusing on finding ways to prevent, treat and ultimately eradicate the disease. It is also home to the Alzheimer's Disease Cooperative Study - a nationwide consortium of institutions designated to carry out clinical trials in Alzheimer's disease in cooperation with the National Institute on Aging - directed by Paul Aisen, MD.

The Neurosciences Institute is dedicated to learning about the brain for the benefit of all mankind. Under the leadership of Nobel Laureate Gerald M. Edelman, the Institute focuses its theoretical and experimental research on the principles underlying how we perceive the world, how we learn and remember, and how consciousness arises.

THE ALZHEIMER'S PROJECT is presented by HBO Documentary Films and the National Institute on Aging at the National Institutes of Health in association with the Alzheimer's Association(R), Fidelity(R) Charitable Gift Fund and Geoffrey Beene Gives Back(R) Alzheimer's Initiative. The series producer is John Hoffman; the executive producers are Sheila Nevins and Maria Shriver.

For more information on THE ALZHEIMER'S PROJECT and Alzheimer's disease, go to HBO.com/alzheimers.


'/>"/>
SOURCE HBO
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Smoking may strongly increase long-term risk of eye disease
3. Pot bellies linked to early signs of cardiovascular disease
4. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
5. Radiologists encouraged to look beyond cancer for clinically unseen diseases
6. Use of certain lipid measures not more effective in predicting coronary heart disease
7. Role seen for cannabis in helping to alleviate allergic skin disease
8. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
9. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
10. New research shows how chronic stress worsens neurodegenerative disease course
11. A new molecular zip code, and a new drug target for Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: